Literature DB >> 6476152

Blood-brain barrier transport and brain sequestration of propranolol and lidocaine.

W M Pardridge, R Sakiyama, G Fierer.   

Abstract

Lipophilic amine drugs such as propranolol and lidocaine are actively sequestered by tissues via saturable cytoplasmic binding systems. The present studies were designed to characterize the kinetics of drug transport and sequestration in rat brain in vivo by using the carotid injection technique. Both propranolol and lidocaine are sequestered by brain, and the half time (t 1/2) of clearance of the drugs from brain to blood is 6-7 min. The t 1/2 of propranolol association and dissociation reactions with the brain sequestration system are 0.38 +/- 0.03 and 1.33 +/- 0.20 min, respectively. The blood-brain barrier transport of propranolol and lidocaine is inhibited by acid pH, and drug transport is mediated by a low-affinity, high-capacity saturable transport system [propranolol half-saturation constant (Km) = 9.8 +/- 1.2 mM, maximal rate of saturable transport (Vmax) = 5.7 +/- 0.7 mumol X min-1 X g-1, and nonsaturable transport constant (KD) = 0.061 +/- 0.012 ml X min-1 X g-1). These studies indicate that in addition to cerebral blood flow, the distribution of lipophilic amines in brain is a function of plasma pH and of the activity of brain sequestration systems. The latter may represent high-capacity cytoplasmic drug-binding proteins that normally bind endogenous ligands in brain.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6476152     DOI: 10.1152/ajpregu.1984.247.3.R582

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

1.  Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models.

Authors:  Stefan Lundquist; Mila Renftel; Julien Brillault; Laurence Fenart; Roméo Cecchelli; Marie-Pierre Dehouck
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

2.  Central nervous system toxicity following topical skin application of lidocaine.

Authors:  Tal Brosh-Nissimov; Merav Ingbir; Iris Weintal; Mordechai Fried; Reuven Porat
Journal:  Eur J Clin Pharmacol       Date:  2004-10-02       Impact factor: 2.953

3.  Propranolol produces short-term facilitation of extinction in a rabbit model of post-traumatic stress disorder.

Authors:  Lauren B Burhans; Carrie A Smith-Bell; Bernard G Schreurs
Journal:  Neuropharmacology       Date:  2018-03-23       Impact factor: 5.250

4.  Tracer kinetic model of blood-brain barrier transport of plasma protein-bound ligands. Empiric testing of the free hormone hypothesis.

Authors:  W M Pardridge; E M Landaw
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

5.  Assessment of drug disposition in the perfused rat brain by statistical moment analysis.

Authors:  T Sakane; M Nakatsu; A Yamamoto; M Hashida; H Sezaki; S Yamashita; T Nadai
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

6.  Lidocaine (lignocaine) dosing regimen based upon a population pharmacokinetic model for preterm and term neonates with seizures.

Authors:  Marcel P H van den Broek; Alwin D R Huitema; Johan G C van Hasselt; Floris Groenendaal; Mona C Toet; Toine C G Egberts; Linda S de Vries; Catharine M A Rademaker
Journal:  Clin Pharmacokinet       Date:  2011-07       Impact factor: 6.447

7.  Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier using in vitro cultured cells and in vivo BUI studies.

Authors:  Y Kido; I Tamai; M Okamoto; F Suzuki; A Tsuji
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

8.  Carrier-mediated transport of H1-antagonist at the blood-brain barrier: a common transport system of H1-antagonists and lipophilic basic drugs.

Authors:  M Yamazaki; T Terasaki; K Yoshioka; O Nagata; H Kato; Y Ito; A Tsuji
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

9.  Nonlinear distribution of atenolol between plasma and cerebrospinal fluid.

Authors:  F M Gengo; S C Fagan; L N Hopkins; D Wagner; D P Schuster
Journal:  Pharm Res       Date:  1989-03       Impact factor: 4.200

10.  "Luxury perfusion" with 99mTc-HMPAO and 123I-IMP SPECT imaging during the subacute phase of stroke.

Authors:  J L Moretti; G Defer; L Cinotti; P Cesaro; J D Degos; N Vigneron; D Ducassou; B L Holman
Journal:  Eur J Nucl Med       Date:  1990
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.